OTCMKTS:CDMGF Icade (CDMGF) Stock Price, News & Analysis $16.62 -6.13 (-26.95%) As of 03:55 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartNews and Trends About Icade Stock (OTCMKTS:CDMGF) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Icade alerts:Sign Up Key Stats Today's Range$16.62▼$16.6250-Day Range$16.62▼$20.1552-Week Range$16.62▼$26.44Volume100 shsAverage Volume500 shsMarket CapitalizationN/AP/E Ratio13.60Dividend Yield22.08%Price TargetN/AConsensus RatingSell Company Overview Icade is a French real estate company that develops, owns, manages and invests in property assets. Its activities have historically focused on commercial real estate, including office buildings, business parks and urban development projects, as well as residential property development. The company also has expertise in healthcare real estate, providing and managing property for healthcare operators such as clinics and care facilities. Icade’s operations are primarily concentrated in France, with a significant presence in the Paris region and other major French urban areas. Founded in 1954 as the real estate subsidiary of Caisse des Dépôts, Icade adopted its current name in 2003. The company remains part of the Caisse des Dépôts group and is led by Chief Executive Officer Nicolas Joly. Icade shares trade on Euronext Paris under the symbol ICAD, and its American OTC-traded shares are quoted under CDMGF.AI Generated. May Contain Errors. Read More Icade Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks20th Percentile Overall ScoreCDMGF MarketRank™: 0.990398526895 of 5 starsIcade scored higher than 20% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion0.7 / 5Analyst RatingSell Consensus RatingIcade has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 2 sell ratings.Amount of Analyst CoverageIcade has only been the subject of 1 research reports in the past 90 days.Read more about Icade's stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Icade is 13.60, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.75.Price to Earnings Ratio vs. SectorThe P/E ratio of Icade is 13.60, which means that it is trading at a less expensive P/E ratio than the Real Estate sector average P/E ratio of about 27.12. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares ShortedShort Interest Ratio / Days to CoverIcade has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Icade has recently decreased by 16.40%, indicating that investor sentiment is improving significantly. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipIcade is a leading dividend payer. It pays a dividend yield of 6.28%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthIcade does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of Icade is 300.37%. Payout ratios above 75% are not desirable because they may not be sustainable.Read more about Icade's dividend. News and Social MediaN/ANews SentimentN/A Company Ownership0.2 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Icade insiders have not sold or bought any company stock.Percentage Held by Institutions19.26% of the stock of Icade is held by institutions.Read more about Icade's insider trading history. Receive CDMGF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Icade and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. CDMGF Stock News HeadlinesIcade (CDMGF) Q2 2026 Earnings Call TranscriptJuly 22, 2026 | seekingalpha.comIcade (CDMGF) Q2 2026 Earnings Call Highlights: Navigating Challenges with Strategic MovesJuly 22, 2026 | finance.yahoo.comI have publicly predicted six major American crashes, before each one happened.Dr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each warning issued before the crisis hit. Now the founder of Weiss Ratings, the only conflict-free rating agency in America, says he is watching a $3 trillion problem that could trigger a chain reaction across markets and banks.October 14 at 1:00 AM | Weiss Ratings (Ad)Icade (CDMGF) Q1 2026 Sales/Trading Call TranscriptApril 17, 2026 | seekingalpha.comIcade: Delayed Asset Sales and Lower Yield Temper Upside Despite Steep NAV Discount, Justifying Hold RatingFebruary 23, 2026 | tipranks.comIcade (CDMGF) Full Year 2025 Earnings Call Highlights: Strategic Disposals and Financial ...February 21, 2026 | finance.yahoo.comIcade (CDMGF) Q4 2025 Earnings Call TranscriptFebruary 18, 2026 | seekingalpha.comIcade price target lowered to EUR 21 from EUR 22 at Deutsche BankDecember 2, 2025 | msn.comSee More Headlines CDMGF Stock Analysis - Frequently Asked Questions How have CDMGF shares performed this year? Icade's stock was trading at $25.00 at the beginning of 2026. Since then, CDMGF stock has decreased by 33.5% and is now trading at $16.62. How do I buy shares of Icade? Shares of CDMGF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorReal Estate Industry Diversified REITs Sub-IndustryDiversified REITs Current SymbolOTCMKTS:CDMGF CIKN/A Webwww.icade.fr Phone33 1 41 57 70 00FaxN/AEmployees1,035Year FoundedN/AProfitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio13.60 Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The 10 Best High-Yield Dividend Stocks for 2026Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.Get This Free Report This page (OTCMKTS:CDMGF) was last updated on 10/14/2026 by MarketBeat.com Staff. From Our PartnersA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredI'm giving you a space stock today. Free.On December 8th, $600 billion in frozen SpaceX stock comes loose. Dylan Jovine says one simple purchase in any...Behind the Markets | SponsoredElon Musk’s One Stock Retirement PlanJeff Brown picked Nvidia in 2016, before it surged 37,000 percent. Now he's tracking a small AI company he say...Brownstone Research | SponsoredDo this before December or regret itPorter Stansberry believes President Trump will use the December G20 Summit in Miami to unveil a radical monet...Porter & Company | SponsoredYou’d Never Guess What Their European Chalet CostEric and Debbie, a couple in their 60s from Burbank, California, retired to a private chalet on a European cou...International Living | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Icade Please log in to your account or sign up in order to add this asset to your watchlist. Share Icade With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.